Trial Profile
Study of intravitreal ziv-aflibercept (Zaltrap) in the treatment choroidal neovascularization secondary to age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Choroidal neovascularisation
- Focus Adverse reactions
- 09 Mar 2017 New trial record